| CSL Behring AG - Tetagam P, Injektionslösung |
| 00673 | | 02 | | Tetagam P | | Injektionslösung | | J06BB02 | | Tetanus Immunoglobulin | | 10.10.2007 | | |
|
| Composition |
| immunoglobulinum humanum tetanicum min. 250 U.I. corresp. immunoglobulinum humanum normale min. 95 % corresp. proteina 100-170 mg, glycinum, natrii chloridum et natrii hydroxidum corresp. natrium 1.6 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Immunoglobulinum Humanum Tetanicum | 250 UI/ml correspond Immunoglobulinum Humanum Normale 95 %/ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Glycin | | Sodium Chloride | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | syringe(s) | PR | PR | B | | Yes |
|
